These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15866525)

  • 1. Development of high-throughput assay of lethal factor using native substrate.
    Kim J; Choi MK; Koo BS; Yoon MY
    Anal Biochem; 2005 Jun; 341(1):33-9. PubMed ID: 15866525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
    Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
    J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
    Kim J; Park HC; Gedi V; Park HY; Roberts AG; Atkins WM; Yoon MY
    Biochem Biophys Res Commun; 2011 Jan; 404(1):517-22. PubMed ID: 21144836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
    Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
    Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
    Joshi M; Ebalunode JO; Briggs JM
    Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening inhibitors of anthrax lethal factor.
    Tonello F; Seveso M; Marin O; Mock M; Montecucco C
    Nature; 2002 Jul; 418(6896):386. PubMed ID: 12140548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the anthrax lethal factor.
    Pannifer AD; Wong TY; Schwarzenbacher R; Renatus M; Petosa C; Bienkowska J; Lacy DB; Collier RJ; Park S; Leppla SH; Hanna P; Liddington RC
    Nature; 2001 Nov; 414(6860):229-33. PubMed ID: 11700563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of anthrax lethal factor in serum by mass spectrometry.
    Boyer AE; Quinn CP; Woolfitt AR; Pirkle JL; McWilliams LG; Stamey KL; Bagarozzi DA; Hart JC; Barr JR
    Anal Chem; 2007 Nov; 79(22):8463-70. PubMed ID: 17929949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized production and purification of Bacillus anthracis lethal factor.
    Park S; Leppla SH
    Protein Expr Purif; 2000 Apr; 18(3):293-302. PubMed ID: 10733882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exceptionally Selective Substrate Targeting by the Metalloprotease Anthrax Lethal Factor.
    Turk BE
    Adv Exp Med Biol; 2019; 1111():189-203. PubMed ID: 30267305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
    Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
    Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.
    Thomas M; Castignetti D
    J Microbiol Immunol Infect; 2009 Aug; 42(4):284-9. PubMed ID: 19949750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
    Vitale G; Pellizzari R; Recchi C; Napolitani G; Mock M; Montecucco C
    Biochem Biophys Res Commun; 1998 Jul; 248(3):706-11. PubMed ID: 9703991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational dynamics of the anthrax lethal factor catalytic center.
    Dalkas GA; Chasapis CT; Gkazonis PV; Bentrop D; Spyroulias GA
    Biochemistry; 2010 Dec; 49(51):10767-9. PubMed ID: 21121613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzymatic electrochemiluminescence assay for the lethal factor of anthrax.
    Rivera VR; Merrill GA; White JA; Poli MA
    Anal Biochem; 2003 Oct; 321(1):125-30. PubMed ID: 12963063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
    Xu L; Frucht DM
    Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease.
    Kimura RH; Steenblock ER; Camarero JA
    Anal Biochem; 2007 Oct; 369(1):60-70. PubMed ID: 17586456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of host signalling pathways by anthrax toxins.
    Turk BE
    Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of pH in the catalytic properties of anthrax lethal factor.
    Kim J; Chai YG; Yoon MY
    Biochem Biophys Res Commun; 2004 Jan; 313(1):217-22. PubMed ID: 14672720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.